Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress

ITO, K., SCOTT, S.A., CUTLER, S., DONG, L.-F., NEUŽIL, J., BLANCHARD, H., RALPH, S.J. Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress. Angiogenesis. 2011, 14(3), 293-307. ISSN 0969-6970. E-ISSN 1573-7209. Dostupné z: doi: 10.1007/s10456-011-9213-5